Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.4B | 1.5B | 817.2M |
Cost of revenue | 1.0B | 1.0B | 1.1B | 494.2M |
Gross profit | 365.5M | 380.3M | 438.0M | 322.9M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 208.8M | 221.4M | 284.5M | 197.9M |
Operating income | 92.3M | 95.1M | 92.5M | 65.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 67.5M | 76.9M | 73.2M | 57.6M |
Other income expense | — | — | — | — |
Pretax income | 28.7M | 20.3M | 21.4M | 10.3M |
Tax provision | 8.7M | 3.8M | 4.5M | 3.1M |
Net income | 20.0M | 16.5M | 16.8M | 7.1M |
Basic EPS | — | 0.3 | 0.3 | 0.1 |
Diluted EPS | — | 0.3 | 0.3 | 0.1 |
Basic average shares | — | 66.0M | 64.8M | 64.8M |
Diluted average shares | — | 66.0M | 64.8M | 64.8M |
EBITDA | 118.3M | 117.6M | 115.0M | 88.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |